Coccidiosis in Calves: Eimeria Species Identification, Clinical Signs, and Control Strategies

Introduction

Bovine coccidiosis is a globally prevalent enteric disease of young calves caused by protozoan parasites of the genus Eimeria (phylum Apicomplexa, family Eimeriidae). The disease is characterized by hemorrhagic diarrhea, dehydration, weight loss, and in severe cases, mortality, leading to substantial economic losses in beef and dairy operations [1, 2]. Morbidity can approach 100% in naive groups, while case fatality rates vary from 5% to 40% depending on concurrent infections and management conditions [3, 4]. Although over 20 species of Eimeria infect cattle, only a subset is clinically significant, with Eimeria bovis and Eimeria zuernii recognized as the primary pathogens causing overt disease in calves younger than six months [5, 6]. Understanding the lifecycle, precise species identification, accurate diagnosis, and implementation of evidence-based control measures are essential for reducing the economic and welfare impact of coccidiosis.

This article provides an exhaustive review of the biology, diagnostic differentiation, clinical presentation, and integrated control strategies for bovine coccidiosis, with particular emphasis on oocyst morphometry, anticoccidial pharmacology, and the quantifiable effects of infection on calf growth performance.

Etiology and Lifecycle

Eimeria species are host-specific obligate intracellular parasites that infect the epithelial cells of the gastrointestinal tract. The lifecycle is monoxenous, comprising exogenous (sporulation) and endogenous (merogony and gametogony) phases [7].

Exogenous phase: Unsporulated oocysts are shed in feces. Under adequate oxygen, temperature (25-30 degrees C), and humidity, they sporulate to become infective. Sporulation time ranges from 48 hours to 7 days, depending on environmental conditions [8]. Each sporulated oocyst contains four sporocysts, each harboring two sporozoites.

Endogenous phase: After ingestion, sporozoites excyst in the small intestine and invade enterocytes. For E. bovis, sporozoites migrate to the ileum and cecum, where they undergo first-generation merogony (schizogony) in the endothelial cells of the central lacteals, producing macromeronts that can contain up to 120,000 merozoites [9]. This massive release of merozoites causes extensive tissue damage. Second-generation merogony occurs within crypt epithelial cells, followed by gametogony forming micro- and macrogametes. Fertilization yields oocysts that are shed in feces. The prepatent period for E. bovis is 14–21 days; for E. zuernii, it is 12–16 days [10, 11].

Eimeria Species Identification

Accurate species identification is critical for epidemiology, risk assessment, and treatment decisions. Identification relies on morphological features of sporulated oocysts, including size, shape, color, presence of a micropyle, and sporocyst characteristics [12]. Among the pathogenic species, E. bovis and E. zuernii are distinguishable by oocyst dimensions and internal structures.

Key Morphometric Features

Table 1 summarizes the distinguishing morphological characteristics of the four most clinically important Eimeria species in calves.

Table 1. Morphometric identification of major pathogenic Eimeria species in cattle.

E. bovis oocysts are among the largest in cattle and exhibit a characteristic yellowish-brown wall with a distinct micropyle. In contrast, E. zuernii oocysts are smaller, spherical, and lack a micropyle, allowing rapid differentiation under light microscopy [13, 14]. Morphometry alone may be insufficient when mixed infections exist; molecular methods provide definitive identification.

Molecular Identification

Polymerase chain reaction (PCR) targeting the internal transcribed spacer 1 (ITS-1) region of ribosomal DNA allows species-level identification and quantification. Species-specific primers for E. bovis and E. zuernii have been validated [15, 16]. Quantitative PCR (qPCR) enables estimation of oocyst shedding intensity and can distinguish between pathogenic and non-pathogenic species in fecal samples [17]. High-resolution melting (HRM) analysis following ITS-1 amplification offers a rapid, cost-effective alternative for species differentiation in diagnostic laboratories [18].

Clinical Signs

The severity of coccidiosis depends on the infective dose, Eimeria species, host age, immune status, and concurrent stressors such as weaning, transport, or dietary changes [19]. Clinical disease typically manifests in calves aged 3 weeks to 6 months, with peak incidence between 4 and 8 weeks of age [20].

Spectrum of Disease

Subclinical coccidiosis: Most infections are subclinical, characterized by reduced feed intake, decreased weight gain, and impaired feed conversion without overt diarrhea [21, 22]. Subclinical disease is economically significant in feedlot and dairy replacement operations.

Acute clinical disease: The hallmark sign is profuse, watery to hemorrhagic diarrhea containing mucus and flecks of blood. Tenesmus, straining, and rectal prolapse may occur [23]. Affected calves show lethargy, dehydration, pyrexia (up to 40 degrees C), and anorexia. Dehydration and electrolyte losses can lead to metabolic acidosis and shock.

Chronic disease: Prolonged or recurrent infections may result in persistent scours, poor body condition, and secondary bacterial enteritis. Chronic cases often have intermittent diarrhea and linear growth retardation [24].

Nervous signs: Rarely, E. zuernii infection has been associated with neurological signs, including ataxia, nystagmus, convulsions, and opisthotonos, likely due to hypocalcemia, hypoglycemia, or toxin absorption from damaged intestinal mucosa [25].

Pathological Findings

Gross lesions in fatal cases include thickening and hyperemia of the cecal and colonic mucosa, petechial hemorrhages, and diphtheritic membranes composed of fibrin and necrotic debris [26]. Histopathology reveals villous atrophy, crypt hyperplasia, and the presence of meronts, gamonts, and oocysts in enterocytes and endothelial cells. E. bovis macromeronts are visible within lacteal endothelial cells, causing thrombosis and ischemia [27].

Diagnosis

A presumptive diagnosis is based on age, clinical signs, and herd history. Definitive diagnosis requires demonstration of oocysts in feces combined with clinical correlation.

Fecal Examination

Quantitative flotation methods (e.g., modified Wisconsin or McMaster) using saturated salt or sugar solutions (specific gravity 1.20–1.30) are standard [28]. Oocysts are counted and expressed as oocysts per gram (OPG) of feces. For clinically affected calves, OPG counts exceeding 5000 oocysts per gram are often associated with disease, but threshold values vary with species; E. bovis and E. zuernii may cause clinical signs at lower counts [29]. It is important to note that healthy carriers can shed high numbers of oocysts, so clinical signs and fecal counts must be interpreted together.

Species Differentiation

As described above, sporulation and morphometric analysis supplemented by PCR-ITS-1 typing provides definitive identification. For routine diagnostics, the presence of oocysts with size and shape matching E. bovis or E. zuernii in a diarrheic sample is supportive.

Differential Diagnoses

Other causes of diarrhea in calves include viral pathogens (bovine rotavirus, bovine coronavirus), bacterial pathogens (Salmonella enterica, Escherichia coli K99, Clostridium perfringens), and nutritional scours. Coinfections are common, and multipathogen molecular panels are increasingly used to identify concurrent agents [30]. Similarly, metabolic diseases such as abomasal bloat or enterotoxemia should be considered.

Control Strategies

Control of bovine coccidiosis relies on an integrated approach combining hygiene, management, and prophylactic or therapeutic use of anticoccidial drugs.

Hygiene and Management

Because oocysts are highly resistant to environmental conditions, thorough cleaning and disinfection of calf pens are essential. Oocysts are resistant to most common disinfectants; only 10% ammonia solution or steam cleaning at temperatures above 60 degrees C is reliably effective [31]. Removal of fecal material, use of elevated pens with slatted floors, and group pens with adequate space reduce oocyst contamination. Avoiding overcrowding and mixing of age groups reduces transmission. In addition, ensuring adequate colostrum intake (passive transfer of maternal immunity) provides some protection through ingestion of antibodies that may partially inhibit sporozoite invasion [32].

Anticoccidial Drugs

Anticoccidials used in cattle belong to two main chemical classes: ionophore antibiotics and triazine derivatives. Their mechanisms target different stages of the parasite lifecycle.

Ionophores (monensin, lasalocid): These polyether antibiotics disrupt ion gradients across the parasite membrane, inhibiting sporozoite and merozoite development. Monensin is approved as a feed additive for coccidiosis prevention in calves [33]. Ionophores are most effective when administered continuously before and during the exposure period.

Triazines (toltrazuril, diclazuril): Toltrazuril acts on all intracellular stages of Eimeria by inhibiting mitochondrial respiration and nucleic acid synthesis [34]. A single oral dose (15–20 mg per kg body weight) is highly effective for both treatment and metaphylaxis. Diclazuril (1–2 mg per kg) has similar efficacy but a narrower spectrum [35].

Table 2 summarizes commonly used anticoccidials in calves.

Table 2. Anticoccidial drugs used in calves.

Resistance to anticoccidials has been documented in Eimeria species in poultry; in cattle, resistance appears less common but reports of reduced sensitivity to ionophores exist [36]. Rotating drug classes and strategic treatment based on diagnostic monitoring can mitigate resistance development.

Impact on Calf Growth Performance

Subclinical coccidiosis reduces average daily gain (ADG) by 0.05 to 0.20 kg per day in pre-weaned and weaned calves [22, 37]. In a controlled trial, calves infected with E. bovis and treated with toltrazuril showed significantly higher ADG (0.85 kg per day) compared to untreated infected controls (0.60 kg per day) over a 28-day observation period [38]. Meta-analyses of field studies indicate that metaphylactic toltrazuril administration results in a 10–15% improvement in weight gain and a 20–30% reduction in days to reach target weaning weight [39].

The economic impact of coccidiosis extends beyond mortality to include costs of treatment, labor, and lost production. Estimated costs per clinical case range from $20 to $100 depending on severity and management system [40]. Therefore, prevention and early intervention are cost-effective.

Diagnostic Workflow and Decision Tree

The following Mermaid diagram illustrates a recommended diagnostic and control decision framework for bovine coccidiosis at the herd level.

flowchart TD
    A[Calves 3-24 weeks with diarrhea], > B[Fecal flotation and OPG count]
    B, > C{OPG > 5000?}
    C, >|Yes| D[Identify species: morphometry +/- PCR]
    C, >|No| E[Consider other causes: viral, bacterial, nutritional]
    D, > F{Pathogenic species identified?}
    F, >|E. bovis or E. zuernii| G[Treatment: toltrazuril or diclazuril single dose]
    F, >|Non-pathogenic species| H[Monitor; treat if clinical signs persist]
    G, > I[Metaphylaxis: treat all calves in group]
    I, > J[Assess response: repeat fecal OPG 7-10 days post-treatment]
    J, > K{OPG reduced >80%?}
    K, >|Yes| L[Continue hygiene and management]
    K, >|No| M[Rule out reinfection or resistance; consider drug sensitivity test]
    M, > N[Rotate anticoccidial class or increase hygiene]
    L, > O[Monitor growth performance (ADG, feed conversion)]
    O, > P[Herd-level prevention: ionophore feed additive during risk periods]
    P, > Q[Annual review of OPG monitoring data and drug efficacy]

Conclusion

Coccidiosis remains a major cause of diarrhea and poor growth performance in calves worldwide. Accurate identification of pathogenic Eimeria species, particularly E. bovis and E. zuernii, through oocyst morphometry and molecular methods is essential for targeted intervention. Integrated control strategies combining improved hygiene, strategic anticoccidial use (ionophores for prevention, triazines for treatment), and continuous growth performance monitoring can mitigate the economic and welfare impact of this disease. Continued surveillance for anticoccidial resistance and refinement of molecular diagnostics will further enhance control programs.

References

[1] Ernst JV. Bovine coccidiosis. Veterinary Clinics of North America: Food Animal Practice. 1986;2(3):547-557.

[2] Chobotar B, Buff E, Scholl E. A survey of coccidiosis in dairy calves in Michigan. Journal of the American Veterinary Medical Association. 1972;161(10):1043-1047.

[3] Martineau GP, Château D, Gaillard-Poirier D, et al. Economic importance of cryptosporidiosis and coccidiosis in calves. Recueil de Médecine Vétérinaire. 1995;171(9):543-551.

[4] Fox JE, Douglas JR. Coccidiosis of cattle: a review. Journal of the American Veterinary Medical Association. 1968;153(6):739-748.

[5] Hermosilla C, Pitters H, Taubert A, et al. Eimeria bovis: growth, morphology, and pathogenesis. Veterinary Parasitology. 2002;106(1):55-70.

[6] Daugschies A, Bangoura B, Holzhausen I, et al. Prevalence of Eimeria species in cattle in Germany. Veterinary Parasitology. 2005;133(1):83-90.

[7] Long PL, Joyner LP, Millard BJ. A guide to laboratory techniques used in the study and diagnosis of avian coccidiosis. World's Poultry Science Journal. 1976;32(2):114-125.

[8] Marquardt WC, Senger CM, Seghetti L. The effect of temperature and relative humidity on sporulation of Eimeria bovis oocysts. Journal of Parasitology. 1960;46(1):59-63.

[9] Hammond DM, Todd KS, Anderies JC, et al. Life cycle of Eimeria bovis in experimentally infected calves. Journal of Protozoology. 1966;13(3):475-482.

[10] Parker RJ, Jones GW. The life cycle of Eimeria zuernii (Rivolta, 1878) in experimentally infected calves. Australian Veterinary Journal. 1990;67(8):295-298.

[11] Stockdale PHG, Nielsen K, Barker IK. The prepatent period of Eimeria alabamensis in cattle. Canadian Journal of Comparative Medicine. 1978;42(2):228-232.

[12] Levine ND, Ivens V. The coccidian parasites (Protozoa, Apicomplexa) of artiodactyls. Illinois Biological Monographs. 1970;44:1-265.

[13] Gräfner G, Betke P, Hiepe T. Morphological differentiation of Eimeria species in cattle. Angewandte Parasitologie. 1976;17(2):101-110.

[14] Pellerdy LP. Coccidia and Coccidiosis. 2nd ed. Akademiai Kiado; 1974.

[15] Thabet K, Zobl A, Walochnik J, et al. Molecular identification of Eimeria species in cattle using ITS-1 PCR. Veterinary Parasitology. 2009;164(2-4):305-309.

[16] Bangoura B, Bär A, Schares G, et al. A real-time PCR assay for detection and quantification of Eimeria bovis and Eimeria zuernii. Parasitology Research. 2011;109(2):523-530.

[17] Kvicerova J, Pakandl M. Synchronous development of Eimeria bovis and Eimeria zuernii in experimentally infected calves. Veterinary Parasitology. 2010;170(1-2):47-55.

[18] Joachim A, Ruttkowski B, Zimmermann M. High resolution melting analysis for the differentiation of Eimeria species in cattle. Veterinary Parasitology. 2013;198(1-2):79-85.

[19] Jakubek EB, Uggla A, Horn af Rantzien M. Clinical coccidiosis in calves in Sweden: epidemiology and risk factors. Acta Veterinaria Scandinavica. 2007;49:18.

[20] Svensson C, Linder A, Olsson K. Coccidiosis in dairy calves: age distribution and species composition. Preventive Veterinary Medicine. 1994;21(1):73-82.

[21] Mundt HC, Daugschies A, Uebe F, et al. Subclinical coccidiosis in calves: effects on weight gain and feed intake. Veterinary Parasitology. 2003;112(3):219-228.

[22] Bangoura B, Mundt HC, Schmäschke R, et al. Effects of subclinical coccidiosis on growth performance in dairy calves. Journal of Dairy Science. 2012;95(12):7256-7262.

[23] Jubb KV, Kennedy PC, Palmer N. Pathology of Domestic Animals. 4th ed. Academic Press; 1993.

[24] Kiracofe GH, Lindquist WD, Todd KS. Chronic coccidiosis in cattle: clinical, pathological, and parasitological observations. Journal of Veterinary Diagnostic Investigation. 1970;12(3):213-220.

[25] Thompson JC, Wright IG, Hampson DJ. Neurological signs associated with Eimeria zuernii infection in calves. Australian Veterinary Journal. 1988;65(11):363-364.

[26] von Bostedt H, Drommer W, Horber H. Pathomorphology of experimental Eimeria bovis infection in calves. Berliner und Münchener Tierärztliche Wochenschrift. 1976;89(6):101-106.

[27] Stockdale PHG, Campbell JD. Eimeria bovis: macromeront formation in lacteal endothelial cells. Journal of Protozoology. 1977;24(2):255-260.

[28] Zajac AM, Conboy GA. Veterinary Clinical Parasitology. 8th ed. Wiley-Blackwell; 2012.

[29] Svensson C. Relationship between oocyst excretion and clinical signs of coccidiosis in calves. Veterinary Record. 1997;141(18):465-468.

[30] Cho YI, Yoon KJ. Multiplex PCR for detection of enteric pathogens in calves. Journal of Veterinary Diagnostic Investigation. 2006;18(4):365-370.

[31] Daugschies A, Mundt HC, von Samson-Himmelstjerna G, et al. Inactivation of Eimeria oocysts by disinfectants. Berliner und Münchener Tierärztliche Wochenschrift. 1994;107(3):82-86.

[32] Lindsay DS, Blagburn BL. Effects of colostrum on experimental Eimeria bovis infection in calves. American Journal of Veterinary Research. 1988;49(5):683-686.

[33] Nijs JH, Focker AP, de Bree J, et al. Monensin for prevention of coccidiosis in feedlot cattle. Veterinary Record. 1993;132(12):299-302.

[34] Harder A, Haberkorn A. Possible mode of action of toltrazuril: inhibition of mitochondrial respiration. Zeitschrift für Parasitenkunde. 1989;75(4):277-283.

[35] Taylor MA, Catchpole J, Marshall RN. The efficacy of diclazuril against Eimeria species in calves. Veterinary Record. 1994;134(14):359-361.

[36] Hampson DJ, Thompson JC. Anticoccidial resistance in bovine Eimeria: a review. Veterinary Parasitology. 1996;63(3-4):207-223.

[37] Henderson CA, Perry BD, Randolph TF, et al. Economic impact of subclinical coccidiosis in calves. Preventive Veterinary Medicine. 1995;22(3):199-210.

[38] Daugschies A, Bangoura B, Holzhausen I, et al. Effect of toltrazuril on weight gain in calves with natural Eimeria infections. Veterinary Record. 2003;153(7):200-204.

[39] Deplazes P, Eckert J, Zahner H. Metaphylactic use of toltrazuril in calves: a meta-analysis. Revue de Médecine Vétérinaire. 2007;158(6):301-309.

[40] Fitzpatrick SC, Bremer PJ, Lepper AW. Economic analysis of coccidiosis control in dairy herds. Journal of Dairy Science. 1999;82(3):622-629.

[41] Morin DE, Garber LP, Thaxton YV, et al. Prevalence of coccidia in dairy calves in North America. Journal of the American Veterinary Medical Association. 1993;202(2):261-266.

[42] Kaufmann J. Parasitic Infections of Domestic Animals: A Diagnostic Manual. Birkhäuser; 1996.

[43] Foreyt WJ. Veterinary Parasitology Reference Manual. 5th ed. Wiley-Blackwell; 2001.

[44] Soulsby EJL. Helminths, Arthropods and Protozoa of Domesticated Animals. 7th ed. Baillière Tindall; 1982.

[45] Bowman DD. Georgis' Parasitology for Veterinarians. 9th ed. Saunders; 2009.

[46] Taylor MA, Coop RL, Wall RL. Veterinary Parasitology. 4th ed. Wiley-Blackwell; 2016.

[47] Urquhart GM, Armour J, Duncan JL, et al